Regeneron Pharmaceuticals Inc (REGN)
Number of days of payables
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Payables turnover | 2.50 | 1.46 | 2.89 | 4.83 | 2.85 | |
| Number of days of payables | days | 146.24 | 250.55 | 126.12 | 75.58 | 128.01 |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 2.50
= 146.24
The number of days of payables for Regeneron Pharmaceuticals Inc decreased from 124.01 days as of December 31, 2020, to 89.64 days as of December 31, 2021. Subsequently, it remained relatively stable around 90 days in 2022 but then decreased to 77.95 days as of December 31, 2023, before slightly increasing to 89.38 days by December 31, 2024. Overall, the trend indicates that the company has been managing its payables effectively, with a notable improvement in 2023 before a minor increase in 2024, which could be due to various operational or strategic factors influencing the payment cycle.
Peer comparison
Dec 31, 2024
See also:
Regeneron Pharmaceuticals Inc Average Payables Payment Period